192 related articles for article (PubMed ID: 11122819)
1. Angiogenesis inhibitors.
Tennant TR; Rinker-Schaeffer CW; Stadler WM
Curr Oncol Rep; 2000 Jan; 2(1):11-6. PubMed ID: 11122819
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis--new drugs on the block.
Brower V
Nat Biotechnol; 1999 Oct; 17(10):963-8. PubMed ID: 10504695
[No Abstract] [Full Text] [Related]
3. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
Rüegg C; Dormond O; Mariotti A
Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
[TBL] [Abstract][Full Text] [Related]
5. Development of new drugs in angiogenesis.
Ziche M; Donnini S; Morbidelli L
Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis inhibitors under study for the treatment of lung cancer.
Shepherd FA; Sridhar SS
Lung Cancer; 2003 Aug; 41 Suppl 1():S63-72. PubMed ID: 12867064
[TBL] [Abstract][Full Text] [Related]
7. Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer.
Sridhar SS; Shepherd FA
Lung Cancer; 2003 Dec; 42 Suppl 1():S81-91. PubMed ID: 14611919
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis inhibitors in cancer therapy.
Dredge K; Dalgleish AG; Marriott JB
Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic inhibitors: a new therapeutic strategy in oncology.
Gasparini G; Longo R; Toi M; Ferrara N
Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
Bikfalvi A; Bicknell R
Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis: a target for cancer therapy.
Tortora G; Melisi D; Ciardiello F
Curr Pharm Des; 2004; 10(1):11-26. PubMed ID: 14754402
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the study of mechanisms of the tumor angiogenesis inhibitors].
Xiao D; Ding J
Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):219-23. PubMed ID: 12532783
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of novel antiangiogenic therapies.
Scappaticci FA
Expert Opin Investig Drugs; 2003 Jun; 12(6):923-32. PubMed ID: 12783597
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis and angiogenesis inhibitors in cancer.
Giavazzi R; Taraboletti G
Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
[TBL] [Abstract][Full Text] [Related]
15. [Research advancement of endogenous angiogenesis inhibitors].
Wu JX; Xu BL; Huang WL
Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
[TBL] [Abstract][Full Text] [Related]
16. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
Caponigro F; Basile M; de Rosa V; Normanno N
Anticancer Drugs; 2005 Feb; 16(2):211-21. PubMed ID: 15655420
[TBL] [Abstract][Full Text] [Related]
17. Current overview of angiogenesis inhibitors.
Ellis LM
Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
[No Abstract] [Full Text] [Related]
18. Angiogenesis inhibitors: a new class of drugs.
Folkman J
Cancer Biol Ther; 2003; 2(4 Suppl 1):S127-33. PubMed ID: 14508090
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor as a target for anticancer therapy.
Ferrara N
Oncologist; 2004; 9 Suppl 1():2-10. PubMed ID: 15178810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
